Efthymios Deliargyris

Efthymios Deliargyris

Chief Tech/Sci/R&D Officer at CYTOSORBENTS CORPORATION

Net worth: 154 084 $ as of 2026-08-30

57 year
Health Technology
Consumer Services
Health Services

Profile

Efthymios N.
Deliargyris
is currently Chief Medical Officer at CytoSorbents Corp.
since 2020.
Formerly, served as Chief Medical Officer at PLx Pharma, Inc. from 2018 to 2020, Director-Cardiology & Interventional Cardiology at Athens Medical Center SA from 2004 to 2010, and Assistant Professor at Wake Forest University from 2001 to 2004.
Education includes a doctorate from National & Kapodistrian University of Athens.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 451,859 ( 0.72% ) 154 084 $ 2026-08-30

Efthymios Deliargyris active positions

CompaniesPositionStart
CYTOSORBENTS CORPORATION Chief Tech/Sci/R&D Officer 2020-04-30

Former positions of Efthymios Deliargyris

CompaniesPositionEnd
PLX PHARMA WINDDOWN CORP. Chief Tech/Sci/R&D Officer 2020-04-29
ATHENS MEDICAL C.S.A. Corporate Officer/Principal 2009-12-31
Corporate Officer/Principal 2003-12-31
See the detail of Efthymios Deliargyris's experience

Training of Efthymios Deliargyris

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Efthymios Deliargyris
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!